%D8%AD%D9%85%D8%B6_%D8%B2%D9%88%D9%84%D9%8A%D8%AF%D8%B1%D9%88%D9%86%D9%8A%D9%83Category:Zoledronic_acidZoledrons%C3%A4ureZoledronic_acid%C3%81cido_zoledr%C3%B3nicoTsoledronihappoAcide_zol%C3%A9droniqueAcido_zoledronico%E3%82%BE%E3%83%AC%E3%83%89%E3%83%AD%E3%83%B3%E9%85%B8ZoledronaatZoledronsyre%E0%AC%9C%E0%AD%8B%E0%AC%B2%E0%AD%87%E0%AC%A1%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%A8%E0%AC%BF%E0%AC%95_%E0%AC%8F%E0%AC%B8%E0%AC%BF%E0%AC%A1Kwas_zoledronowy%C3%81cido_zoledr%C3%B4nico%D0%97%D0%BE%D0%BB%D0%B5%D0%B4%D1%80%D0%BE%D0%BD%D0%BE%D0%B2%D0%B0%D1%8F_%D0%BA%D0%B8%D1%81%D0%BB%D0%BE%D1%82%D0%B0Zoledronska_kiselinaZoledronska_kiselinaAxit_zoledronicQ218507%E5%94%91%E4%BE%86%E7%A3%B7%E9%85%B8
about
Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic WomenPhase 1 Study of Zoledronic Acid in Sickle Cell DiseaseMulti-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer PatientsZoledronate With Atorvastatin in Renal Cell CarcinomaStudy on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate CancerAcetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone MassStudy of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior YearSafety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone LesionsZoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast CancerNeo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer PatientsLow-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerOsteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic AcidPostoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant ChemotherapyZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementComparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)The Effect of Zoledronic Acid on Bone Density in Liver Transplant PatientsLetrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast DensityZoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerA Multiple Myeloma Trial in Patients With Bone MetastasesSafety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation PeriodBisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral DensityZoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneA Prostate Cancer Study in Men Undergoing Androgen Deprivation TherapyNon-small Cell Lung Cancer Study US75 (Z-PACT)Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No SymptomsZoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic OsteosarcomaA Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma PatientsRe-treatment of Patients With Paget's Disease Using Zoledronic AcidStage I Multiple Myeloma TreatmentHypofractionated Stereotactic Body Radiation Therapy and Fluorouracil or Capecitabine With or Without Zoledronic Acid in Treating Patients With Locally Advanced Pancreatic CancerStudy of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone ZométaComparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone MassFES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI)Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema SyndromeTHAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)The Efficacy of Zoledronic Acid in Modic Changes-related Low Back Pain (LBP)The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody FusionStem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple MyelomaPilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric SurgeryBisphosphonates for Prevention of Post-Denosumab Bone Loss
P4844
P527
Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventionsA comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.Chitosan-Based Polyelectrolyte Complexes for Doxorubicin and Zoledronic Acid Combined Therapy to Overcome Multidrug ResistanceA protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2Managing thymic enlargement in Graves' diseaseDenosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trialSkeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: mouse strain disparities and synergic effect with zoledronic acidPreclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignanciesMolecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bonePrevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonatesMazabraud's Syndrome: A Case Report And Up-To-Date Literature ReviewTargeting the bone marrow microenvironment: a novel therapeutic strategy for pre-B acute lymphoblastic leukemiaEfficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case reportRisk factors of medication-related osteonecrosis of the jaw: a retrospective study in a Turkish subpopulationZoledronic acid blocks the interaction between breast cancer cells and regulatory T-cellsZoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathwaysZoledronic Acid Modulation of TRPV1 Channel Currents in Osteoblast Cell Line and Native Rat and Mouse Bone Marrow-Derived Osteoblasts: Cell Proliferation and Mineralization EffectResponse to Zoledronic Acid in Patients with Active Paget's Disease of Bone: A Retrospective StudyAdministration of Intravenous Zoledronic Acid Every 3 Months vs. Annually in β-thalassemia Patients with Low Bone Mineral Density: a Retrospective Comparison of Efficacy
P921
Q61909442-6B0481BE-BFF4-4975-8FBE-358BFCB9887AQ61915029-5433D9D6-E9C6-43D9-8510-4A3FD52C8923Q61915298-138ADE29-EDDE-4F6F-8A5D-8DC7E0470FACQ61918033-07955F0A-3666-47CF-8E74-EDEA58CAAFF2Q61918103-CAFAEED5-02A0-49D1-A2DF-BB6433D4D6E7Q61918145-56C4C848-40C9-43E0-9FB9-E091645660BFQ61921549-326B2C13-E7FA-4FE7-9DA5-FE4A1D00C9D8Q61932904-60F0AFF3-785E-41E7-AD91-13BF4C5F58B4Q61934392-449A61E8-99B9-4F0B-93E2-D7B1BD59C472Q61936211-D8610B9E-8F48-4542-BDD2-681FD03C3F58Q61939089-867E8D79-16B2-4E78-905B-C20406648D14Q61975612-78CCBB49-5A99-44DA-A16B-D558F49BB282Q61978991-4AAE8573-7C93-4F67-9C8E-187D476D00BCQ61980743-9F2F9BF9-D2C2-4F59-A89B-C06DCA7D94B4Q62062050-729986C5-979F-4650-991B-47DED285E48EQ62104851-3035E537-8433-4AAD-82EA-DE371665BCADQ62104878-01601582-E3BC-4D4A-9728-4A9760B2131BQ62105633-0DEBEAEB-7407-4648-A9A7-4AC4502ABF06Q62105903-731DA5D2-0806-4C06-9EFA-8FBFD2C94CF1Q62105937-C49E4F99-0000-4C49-96E6-D1C1583ABCBCQ62106151-C5860736-4744-4984-B4D3-A6418BFC1C37Q62110272-2B455DB5-A2F3-42BF-ADC1-21E4A09A2602Q62110387-B0752A07-AE6A-4CEB-80F6-4E707E98FA9AQ62110527-80D77BB5-6A55-4B8E-AE2B-95ADE4CAE96BQ62110620-43896F89-ADAA-41F2-B1AF-7F8439E7C942Q63062537-C16EAB9D-4664-4FB9-98D9-9463E76B370BQ63062700-B7E63320-45CE-4CC6-87D9-95CAC0962BFCQ63062850-A4C47550-6C5E-427D-8A81-DA42EBE9F366Q63063690-C113A43D-5B23-4528-A25A-D4DACBB243B9Q63228842-BA709372-3A47-4A9E-B7DD-84716C0374D1Q63315899-2A0950E6-1890-4596-B505-620B120A2FC8Q63316305-7DA92597-96BE-4E67-A134-8E25A28BCD8EQ63321099-B3B29145-C9A3-4D77-ADE9-56055455AD58Q63335529-B8C225AF-FCB2-4522-9706-9DCAD2905DA6Q63337984-B300DF19-35B5-4954-9378-85CD0F382736Q63338046-745593B2-D04E-4D0E-B838-A084F1E7250EQ63339317-777D707E-7EE3-4DAE-862E-776AB40262A3Q63340859-211C82A9-E39D-445B-A223-3909BF7F625AQ63402219-D0836E79-10D7-4B22-9829-58AFC5E92B52Q63403604-EBC9455F-2970-4710-9D38-A5C3E1CE31AF
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Axit zoledronic
@vi
Kwas zoledronowy
@pl
Tsoledronihappo
@fi
Zoledronaat
@nl
Zoledronska kiselina
@sh
Zoledronska kiselina
@sr
Zoledronsyre
@nb
Zoledronsäure
@de
acide zolédronique
@fr
acido zoledronico
@it
type
label
Axit zoledronic
@vi
Kwas zoledronowy
@pl
Tsoledronihappo
@fi
Zoledronaat
@nl
Zoledronska kiselina
@sh
Zoledronska kiselina
@sr
Zoledronsyre
@nb
Zoledronsäure
@de
acide zolédronique
@fr
acido zoledronico
@it
altLabel
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
@en
(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
@en
Acido zoledronico
@es
Aclasta®
@en
Anhydrous Zoledronic Acid
@en
CGP-42446
@en
CGP-42446A
@en
Reclast®
@en
ZOL
@en
ZOL446
@en
prefLabel
Axit zoledronic
@vi
Kwas zoledronowy
@pl
Tsoledronihappo
@fi
Zoledronaat
@nl
Zoledronska kiselina
@sh
Zoledronska kiselina
@sr
Zoledronsyre
@nb
Zoledronsäure
@de
acide zolédronique
@fr
acido zoledronico
@it